{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:23:34Z","timestamp":1791897814012,"version":"4.3.4"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T00:00:00Z","timestamp":1620864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Obesity has been demonstrated to show a consistent link with the increased possibility of nonalcoholic fatty liver disease (NAFLD). Since both serum uric acid (SUA) and obesity are essential components of metabolic syndrome (MetS), it is uncertain whether the incidence of NAFLD results from serum uric acid, obesity, or other potential factors based on previous studies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients and methods<\/jats:title><jats:p>This study enrolled 16,839 participants with no history of alcohol consumption and no fatty liver disease in 2010. All participants completed a survey which included health and lifestyle questionnaires, and underwent physical examination, ultrasonography, and laboratory examinations of blood samples. After the four-year follow up, 5,104 (30.31%) participants were diagnosed with NAFLD. The associations between SUA, BMI or obesity, and incident NAFLD were assessed by multivariate linear regression, logistic regression analysis, and mediation analysis, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>By adjusting demographic and serum characteristics, linear correlation coefficients between obesity and SUA were 20.26 [95% confidence interval (CI)]: 15.74, 24.77), 13.31 (95% CI: 6.63, 19.99) and 22.21 (95% CI: 16.41, 28.02) in the total population, and in the female and male groups, respectively. The odds ratios were 2.49 (95% CI: 1.61, 3.87) in the total population, 5.71 (95% CI: 2.25, 14.45) in the female group and 1.99 (95% CI: 1.15, 3.45) in the male group for the correlation between obesity and incident NAFLD. The mediation analysis showed that SUA contributed to 10.03%, 0.58%, and 12.54% of obesity-related NAFLD development in the total population, females and males, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The findings showed mediation linkages of both obesity and SUA with the incident NAFLD. The role of SUA as a mediator constitutes clinical significance that should be recognized and considered.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2021.657856","type":"journal-article","created":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T14:40:38Z","timestamp":1620916838000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Serum Uric Acid Is a Mediator of the Association Between Obesity and Incident Nonalcoholic Fatty Liver Disease: A Prospective Cohort Study"],"prefix":"10.3389","volume":"12","author":[{"given":"Qian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runkuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuohua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shutian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29367","article-title":"The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance From the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatol (Baltimore Md)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.metabol.2017.04.011","article-title":"Non-Alcoholic Fatty Liver Disease: A Sign of Systemic Disease","volume":"72","author":"Reccia","year":"2017","journal-title":"Metabol: Clin Exp"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: A Multisystem Disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J Hepatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The Global Epidemiology of NAFLD and NASH in Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-Alcoholic Fatty Liver Disease -\u00a0a Global Public Health Perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-Alcoholic Fatty Liver Disease and Risk of Incident Cardiovascular Disease: A Meta-Analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J Hepatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and Increased Risk of Cardiovascular Disease: Clinical Associations, Pathophysiological Mechanisms and Pharmacological Implications","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2015.11.026","article-title":"Uric Acid in Metabolic Syndrome: From an Innocent Bystander to a Central Player","volume":"29","author":"Kanbay","year":"2016","journal-title":"Eur J Internal Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.12056","article-title":"Diagnosis and Management of non-Alcoholic Fatty Liver Disease and Related Metabolic Disorders: Consensus Statement From the Study Group of Liver and Metabolism, Chinese Society of Endocrinology","volume":"5","author":"Gao","year":"2013","journal-title":"J Diabetes"},{"key":"B10","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41598-017-18854-1","article-title":"Body Mass Index, Waist Circumference, and Waist-to-Height Ratio for Prediction of Multiple Metabolic Risk Factors in Chinese Elderly Population","volume":"8","author":"Gu","year":"2018","journal-title":"Sci Rep"},{"key":"B11","doi-asserted-by":"publisher","first-page":"109158","DOI":"10.1016\/j.biopha.2019.109158","article-title":"Gender Effect of Hyperuricemia on the Development of Nonalcoholic Fatty Liver Disease (NAFLD): A Clinical Analysis and Mechanistic Study","volume":"117","author":"Xu","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.111.963694","article-title":"Prevalence of Ideal Cardiovascular Health and its Relationship With the 4-Year Cardiovascular Events in a Northern Chinese Industrial City","volume":"5","author":"Wu","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv079","article-title":"Resting Heart Rate and the Risk of Developing Impaired Fasting Glucose and Diabetes: The Kailuan Prospective Study","volume":"44","author":"Wang","year":"2015","journal-title":"Int J Epidemiol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-0610","article-title":"Longitudinal Change in Fasting Blood Glucose and Myocardial Infarction Risk in a Population Without Diabetes","volume":"40","author":"Jin","year":"2017","journal-title":"Diabetes Care"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.116.144832","article-title":"Longitudinal Study of Alcohol Consumption and HDL Concentrations: A Community-Based Study","volume":"105","author":"Huang","year":"2017","journal-title":"Am J Clin Nutr"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.117.020277","article-title":"Longitudinal Change of Perceived Salt Intake and Stroke Risk in a Chinese Population","volume":"49","author":"Li","year":"2018","journal-title":"Stroke"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.109.137653","article-title":"Dissociation of Aortic Pulse Wave Velocity With Risk Factors for Cardiovascular Disease Other Than Hypertension A Systematic Review","volume":"54","author":"Cecelja","year":"2009","journal-title":"Hypertension"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e57319","DOI":"10.1371\/journal.pone.0057319","article-title":"Impact of Waist Circumference and Body Mass Index on Risk of Cardiometabolic Disorder and Cardiovascular Disease in Chinese Adults: A National Diabetes and Metabolic Disorders Survey","volume":"8","author":"Hou","year":"2013","journal-title":"PloS One"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.09270816","article-title":"Sleep and CKD in Chinese Adults: A Cross-Sectional Study","volume":"12","author":"Li","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2010.12.019","article-title":"Intra-Individual Variability of High-Sensitivity C-reactive Protein in Chinese General Population","volume":"157","author":"Wu","year":"2012","journal-title":"Int J Cardiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/jhn.12674","article-title":"Prospective Study of Perceived Dietary Salt Intake and the Risk of non Alcoholic Fatty Liver Disease","volume":"32","author":"Shen","year":"2019","journal-title":"J Hum Nutr Dietetics"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.10476","article-title":"Central and Brachial Blood Pressures, Statins, and Low-Density Lipoprotein Cholesterol: A Mediation Analysis","volume":"71","author":"Lamarche","year":"2018","journal-title":"Hypertension (Dallas Tex: 1979)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2017.12.018","article-title":"Nonalcoholic Fatty Liver Disease as a Sentinel Marker for the Development of Diabetes Mellitus in non-Obese Subjects","volume":"50","author":"Kim","year":"2018","journal-title":"Digest Liver Dis: Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, Incidence, and Outcome of non-Alcoholic Fatty Liver Disease in Asia, 1999-2019: A Systematic Review and Meta-Analysis","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090736","article-title":"Changes in Waist Circumference and Body Mass Index in Relation to Changes in Serum Uric Acid in Japanese Individuals","volume":"37","author":"Ishizaka","year":"2010","journal-title":"J Rheumatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000000931","article-title":"Hyperuricemia is Associated With Nonalcoholic Fatty Liver Disease Activity Score in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis","volume":"29","author":"Jaruvongvanich","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04788.x","article-title":"Hyperuricemia is Associated With Histological Liver Damage in Patients With non-Alcoholic Fatty Liver Disease","volume":"34","author":"Petta","year":"2011","journal-title":"Alimentary Pharmacol Ther"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12656","article-title":"The Independent Predictors of non-Alcoholic Steatohepatitis and its Individual Histological Features.: Insulin Resistance, Serum Uric Acid, Metabolic Syndrome, Alanine Aminotransferase and Serum Total Cholesterol are a Clue to Pathogenesis and Candidate Targets for Treatment","volume":"46","author":"Ballestri","year":"2016","journal-title":"Hepatol Res: Off J Japan Soc Hepatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13329","article-title":"Hyperuricaemia and Risk of Nonalcoholic Fatty Liver Disease: A\u00a0Meta-Analysis","volume":"37","author":"Wijarnpreecha","year":"2017","journal-title":"Liver Int: Off J Int Assoc Study Liver"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e6381","DOI":"10.1097\/MD.0000000000006381","article-title":"Combined Effect of Obesity\u00a0and Uric Acid on Nonalcoholic Fatty Liver Disease and Hypertriglyceridemia","volume":"96","author":"Zhang","year":"2017","journal-title":"Med (Baltimore)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2014.09.020","article-title":"Nonalcoholic Fatty Liver Disease: A Precursor of the Metabolic Syndrome","volume":"47","author":"Lonardo","year":"2015","journal-title":"Digest Liver Dis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/srep14325","article-title":"Dose-Response Relationship of Serum Uric Acid With Metabolic Syndrome and Non-alcoholic Fatty Liver Disease Incidence: A Meta-Analysis of Prospective Studies","volume":"5","author":"Liu","year":"2015","journal-title":"Sci Rep"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-2527","article-title":"Serum Uric Acid Levels and Risk of Metabolic Syndrome: A Dose-Response Meta-Analysis of Prospective Studies","volume":"100","author":"Yuan","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13063","article-title":"The Relationship Between Serum Uric Acid Levels and the Major Risk Factors for the Development of Nonalcoholic Fatty Liver Disease","volume":"36","author":"Ozcelik","year":"2016","journal-title":"Liver Int"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.657856\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T14:40:43Z","timestamp":1620916843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.657856\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,13]]},"references-count":34,"alternative-id":["10.3389\/fendo.2021.657856"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.657856","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,13]]},"article-number":"657856"}}